Latest MYOC Stories

Inhibiting the protein, Grp94, could offer new treatment for the sight-robbing eye disease The chaperone protein Grp94 can interfere with the clearance of another protein known to cause the glaucoma when mutated, a new study led by researchers at the University of South Florida has found. Using a cell model, the researchers also demonstrated that a new specific inhibitor of Grp94 facilitates clearance of the genetically-defective protein, called myocilin, from cells. Reported online...

Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it’s permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease. Glaucoma is typically triggered when fluid is unable to circulate freely through the...

(Ivanhoe Newswire) -- By studying a mouse model, researchers have obtained new insights about glaucoma, the second most common cause of blindness in the United States.Glaucoma refers to a group of eye conditions that leads to damage to the optic nerve. This is the nerve that carries visual information from the eye to the brain. In many cases, damage to the optic nerve is due to increased pressure in the eye, also known as intraocular pressure (IOP).There are four forms of glaucoma, and...

An eye under pressure appears to express a unique set of proteins that physicians hope will one day help them better diagnose and treat glaucoma.Glaucoma, the second leading cause of blindness worldwide, tends to progress silently until decreased vision indicates trouble, said Dr. Kathryn Bollinger, Medical College of Georgia clinician-scientist specializing in glaucoma.But inside fluid-filled eyeballs, a changing protein profile "“ 30 with significant increases and 17 with significant...